← Open Payments lookup

MICHAEL CHOI: Open Payments

NPI 1881232429 · ORANGE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$8,049 in 220 payments from 19 companies in 2025. Trend: 2023 $3,940 · 2024 $3,955 · 2025 $8,049

Food & beverage: $5,136Travel & lodging: $2,247Consulting: $555Education: $111
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.25$2,164
Boehringer Ingelheim Pharmaceuticals, Inc.7$1,249
E.R. Squibb & Sons, L.L.C.14$903
Janssen Pharmaceuticals, Inc18$632
ABBVIE INC.27$594
Otsuka America Pharmaceutical, Inc.24$548
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)27$386
Teva Pharmaceuticals USA, Inc.16$380
Vanda Pharmaceuticals Inc.17$344
Alkermes, Inc.12$273

Products named: REXULTI, VRAYLAR, CAPLYTA, SPRAVATO, FANAPT, INGREZZA, INVEGA SUSTENNA, ARISTADA.

Industry payments across CA — which companies pay providers there.